Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Precursor of Artificial Lung Developed

By HospiMedica staff writers
Posted on 01 May 2001
A device that functions like a temporary set of lungs has been developed by Brack Hattler, Ph.D., a professor of surgery at the University of Pittsburgh School of Medicine (UPMC, PA, USA). More...
Although the device is not designed for prolonged support, it is expected to contribute toward the ongoing development of long-term devices, estimated to be two or three years from human testing.

Laboratory and animal studies suggest that the device, called the Hattler Respiratory Catheter, could do an adequate job of exchanging carbon dioxide and oxygen in patients with compromised lungs, allowing the lungs to rest and heal. The device could be of great benefit to patients with emphysema, chest trauma, or acute respiratory distress, as well as to victims of toxic gas inhalation or chemical warfare.

The Hattler Catheter is inserted through a vein in the leg and positioned into the vena cava, the major vein returning blood to the heart. The device consists of hollow fiber membranes that introduce oxygen into the body and remove carbon dioxide. A central balloon within the fibers can inflate and deflate at a rate of 300 beats per minute to move the fibers and mix the blood. In essence, respiration takes place even though the lungs are severely injured and functioning poorly. The extracorporeal membrane oxygenators currently in use can cause life-threatening complications and death in patients.

The device is intended to temporarily take over the function of the lungs. It is not intended to be used for prolonged support, as a bridge to transplant or as a total replacement of the lungs. However, said Dr. Hattler, findings from clinical trials will lead to a greater understanding of what is required for the development of long-term devices. He reported on the device at a meeting of the International Society for Heart and Lung Transplantation in Vancouver (Canada).

"The artificial lung especially has lingered behind progress with artificial hearts and ventricular assist devices, not because the need for lungs has not been recognized, but because we have not had a full understanding of the engineering problems and the unique material requirements until recent years,” explained Dr. Hattler.




Related Links:
UPMC

Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.